Literature DB >> 33676568

ApoE4 (Δ272-299) induces mitochondrial-associated membrane formation and mitochondrial impairment by enhancing GRP75-modulated mitochondrial calcium overload in neuron.

Tao Liang1,2, Weijian Hang1,3, Jiehui Chen1, Yue Wu1, Bin Wen1, Kai Xu1, Bingbing Ding1, Juan Chen4.   

Abstract

BACKGROUND: Apolipoprotein E4 (apoE4) is a major genetic risk factor of Alzheimer's disease. Its C-terminal-truncated apoE4 (Δ272-299) has neurotoxicity by affecting mitochondrial respiratory function. However, the molecular mechanism(s) underlying the action of apoE4 (Δ272-299) in mitochondrial function remain poorly understood.
METHODS: The impact of neuronal apoE4 (Δ272-299) expression on ER stress, mitochondrial-associated membrane (MAM) formation, GRP75, calcium transport and mitochondrial impairment was determined in vivo and in vitro. Furthermore, the importance of ER stress or GRP75 activity in the apoE4 (Δ272-299)-promoted mitochondrial dysfunction in neuron was investigated.
RESULTS: Neuronal apoE4 (Δ272-299) expression induced mitochondrial impairment by inducing ER stress and mitochondrial-associated membrane (MAM) formation in vivo and in vitro. Furthermore, apoE4 (Δ272-299) expression promoted GRP75 expression, mitochondrial dysfunction and calcium transport into the mitochondria in neuron, which were significantly mitigated by treatment with PBA (an inhibitor of ER stress), MKT077 (a specific GRP75 inhibitor) or GRP75 silencing.
CONCLUSIONS: ApoE4 (Δ272-299) significantly impaired neuron mitochondrial function by triggering ER stress, up-regulating GRP75 expression to increase MAM formation, and mitochondrial calcium overload. Our findings may provide new insights into the neurotoxicity of apoE4 (Δ272-299) against mitochondrial function and uncover new therapeutic targets for the intervention of Alzheimer's disease.

Entities:  

Keywords:  Alzheimer’s disease; Apolipoprotein E4; ER stress; Mitochondrial Ca2+ overload; Mitochondria‐associated ER membrane; apoE4 (Δ272–299)

Year:  2021        PMID: 33676568     DOI: 10.1186/s13578-021-00563-y

Source DB:  PubMed          Journal:  Cell Biosci        ISSN: 2045-3701            Impact factor:   7.133


  47 in total

1.  Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons.

Authors:  Y Huang; X Q Liu; T Wyss-Coray; W J Brecht; D A Sanan; R W Mahley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

2.  Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice.

Authors:  I Tesseur; J Van Dorpe; K Spittaels; C Van den Haute; D Moechars; F Van Leuven
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

Review 3.  Mitoenergetic failure in Alzheimer disease.

Authors:  Mordhwaj S Parihar; Gregory J Brewer
Journal:  Am J Physiol Cell Physiol       Date:  2006-06-28       Impact factor: 4.249

Review 4.  Mitochondrial dysfunction: cause and consequence of Alzheimer's disease.

Authors:  Kristina Friedland-Leuner; Carola Stockburger; Isabel Denzer; Gunter P Eckert; Walter E Müller
Journal:  Prog Mol Biol Transl Sci       Date:  2014       Impact factor: 3.622

5.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

Authors:  E H Corder; A M Saunders; W J Strittmatter; D E Schmechel; P C Gaskell; G W Small; A D Roses; J L Haines; M A Pericak-Vance
Journal:  Science       Date:  1993-08-13       Impact factor: 47.728

6.  Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord.

Authors:  I Tesseur; J Van Dorpe; K Bruynseels; F Bronfman; R Sciot; A Van Lommel; F Van Leuven
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

7.  Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice.

Authors:  Walter J Brecht; Faith M Harris; Shengjun Chang; Ina Tesseur; Gui-Qiu Yu; Qin Xu; Jo Dee Fish; Tony Wyss-Coray; Manuel Buttini; Lennart Mucke; Robert W Mahley; Yadong Huang
Journal:  J Neurosci       Date:  2004-03-10       Impact factor: 6.167

Review 8.  Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease.

Authors:  Hani Atamna; William H Frey
Journal:  Mitochondrion       Date:  2007-06-13       Impact factor: 4.160

Review 9.  Genetics of Alzheimer's disease: where we are, and where we are going.

Authors:  Céline Bellenguez; Benjamin Grenier-Boley; Jean-Charles Lambert
Journal:  Curr Opin Neurobiol       Date:  2019-12-18       Impact factor: 6.627

Review 10.  Genetics of Alzheimer's Disease.

Authors:  Jong Hun Kim
Journal:  Dement Neurocogn Disord       Date:  2019-01-24
View more
  7 in total

1.  AKT/PACS2 Participates in Renal Vascular Hyperpermeability by Regulating Endothelial Fatty Acid Oxidation in Diabetic Mice.

Authors:  Zhihao Shu; Shuhua Chen; Hong Xiang; Ruoru Wu; Xuewen Wang; Jie Ouyang; Jing Zhang; Huiqin Liu; Alex F Chen; Hongwei Lu
Journal:  Front Pharmacol       Date:  2022-07-05       Impact factor: 5.988

Review 2.  A Review of ApoE4 Interference Targeting Mitophagy Molecular Pathways for Alzheimer's Disease.

Authors:  Huiyi Chen; Feng Chen; Ying Jiang; Lu Zhang; Guizhen Hu; Furong Sun; Miaoping Zhang; Yao Ji; Yanting Chen; Gang Che; Xu Zhou; Yu Zhang
Journal:  Front Aging Neurosci       Date:  2022-05-20       Impact factor: 5.702

Review 3.  Disentangling Mitochondria in Alzheimer's Disease.

Authors:  Ashu Johri
Journal:  Int J Mol Sci       Date:  2021-10-26       Impact factor: 5.923

4.  Resveratrol Treatment in Human Parkin-Mutant Fibroblasts Modulates cAMP and Calcium Homeostasis Regulating the Expression of Mitochondria-Associated Membranes Resident Proteins.

Authors:  Anna Signorile; Anna Ferretta; Consiglia Pacelli; Nazzareno Capitanio; Paola Tanzarella; Maria Laura Matrella; Alessio Valletti; Domenico De Rasmo; Tiziana Cocco
Journal:  Biomolecules       Date:  2021-10-14

Review 5.  Apolipoprotein E and Alzheimer's disease.

Authors:  Benjamin R Troutwine; Laylan Hamid; Colton R Lysaker; Taylor A Strope; Heather M Wilkins
Journal:  Acta Pharm Sin B       Date:  2021-10-15       Impact factor: 11.413

6.  Preserving mitochondrial function by inhibiting GRP75 ameliorates neuron injury under ischemic stroke.

Authors:  Bin Wen; Kai Xu; Rui Huang; Teng Jiang; Jian Wang; Jiehui Chen; Juan Chen; Benhong He
Journal:  Mol Med Rep       Date:  2022-03-16       Impact factor: 2.952

Review 7.  Functional diversity of apolipoprotein E: from subcellular localization to mitochondrial function.

Authors:  Johanna Rueter; Gerald Rimbach; Patricia Huebbe
Journal:  Cell Mol Life Sci       Date:  2022-08-26       Impact factor: 9.207

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.